M Anttila
Overview
Explore the profile of M Anttila including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
1167
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Anttila M
Acta Obstet Gynecol Scand
. 2011 Jan;
73(9):739-41.
PMID: 21235530
Diabetic pregnancies are risk pregnancies with increased perinatal mortality and perinatal morbidity. The purpose of this study was to evaluate retrospcctively the outcome of 567 diabetic pregnancies in the area...
12.
Sironen R, Tammi M, Tammi R, Auvinen P, Anttila M, Kosma V
Exp Cell Res
. 2010 Dec;
317(4):383-91.
PMID: 21134368
Hyaluronan, a major macropolysaccharide in the extracellular matrix of connective tissues, is intimately involved in the biology of cancer. Hyaluronan accumulates into the stroma of various human tumors and modulates...
13.
Sallinen H, Anttila M, Grohn O, Koponen J, Hamalainen K, Kholova I, et al.
Cancer Gene Ther
. 2010 Sep;
18(2):100-9.
PMID: 20865022
Despite optimal surgery and chemotherapy, the prognosis of ovarian cancer patients remains poor and new treatments are urgently needed. Solid tumors require the formation of new vessels for growth and...
14.
Sillanpaa S, Anttila M, Suhonen K, Hamalainen K, Turpeenniemi-Hujanen T, Puistola U, et al.
Tumour Biol
. 2007 Oct;
28(5):280-9.
PMID: 17962725
Aims: We investigated the prognostic significance of extracellular matrix metalloproteinase inducer (EMMPRIN) and matrix metalloproteinase 2 (MMP-2) in epithelial ovarian cancer as well as their relation to hyaluronan (HA) expression....
15.
Sillanpaa S, Anttila M, Voutilainen K, Ropponen K, Turpeenniemi-Hujanen T, Puistola U, et al.
Gynecol Oncol
. 2006 Oct;
104(2):296-303.
PMID: 17034838
Objective: We investigated the expression of matrix metalloproteinase-9 (MMP-9) and its relation to clinicopathologic factors and survival and also to previously analyzed expressions of CD44 and hyaluronan in epithelial ovarian...
16.
Fossil M, Ahlsten K, Pohjanvirta T, Anttila M, Kokkonen T, Jensen T, et al.
Acta Vet Scand
. 2006 Jan;
46(4):257-67.
PMID: 16398337
A hippurate-negative biovariant of Brachyspira pilosicoli (B. pilosicolihipp-) is occasionally isolated in diarrhoeic pigs in Finland, often concomitantly with hippurate-positive B. pilosicoli or Lawsonia intracellularis. We studied pathogenicity of B....
17.
Venalainen E, Anttila M, Peltonen K
Bull Environ Contam Toxicol
. 2005 May;
74(3):526-36.
PMID: 15903187
No abstract available.
18.
Laine T, Yliaho M, Myllys V, Pohjanvirta T, Fossi M, Anttila M
Prev Vet Med
. 2004 Dec;
66(1-4):163-74.
PMID: 15579342
The use of the antimicrobial growth promoters (AGPs) carbadox and olaquindox has been banned in the European Union (EU) since September 1999. We studied the effects of the withdrawal on...
19.
Penttila J, Kaila T, Helminen A, Anttila M, Karhuvaara S, Huhtala S, et al.
Auton Autacoid Pharmacol
. 2004 Nov;
24(3):69-75.
PMID: 15541014
1 This double-blind, cross-over, placebo-controlled study on six healthy male volunteers was designed to evaluate the effects of alpha2-adrenoceptor antagonism on cardiac parasympathetic regulation. 2 The subjects received atipamezole intravenously...
20.
Huupponen R, Anttila M, Rouru J, Kanerva H, Miettinen T, Scheinin M
Int J Clin Pharmacol Ther
. 2004 Sep;
42(8):449-55.
PMID: 15366325
Objective: To study the pharmacokinetics and accumulation of deramciclane and its metabolite N-desmethylderamciclane after 60 mg twice daily doses for 4 weeks. Methods: Sixteen healthy male subjects, age range of...